Page 5 - RxExam's Naplex Theory Book Part 2
P. 5
www.pharmacyexam.com Krisman
Table of Contents
38. BENIGN PROSTATIC HYPERPLASIA .......................................................................................................... 6
39. ERYTHROPOIESIS AND COLONY STIMULATING AGENTS ........................................................................ 8
40. HYPERURICEMIA AND GOUT ................................................................................................................. 14
41. IMMUNOSUPPRESSANTS ...................................................................................................................... 20
42. ANTI-MIGRAINE..................................................................................................................................... 30
43. ANTI-EMETIC AGENTS ........................................................................................................................... 38
44. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS .................................................................................. 47
45. OPIOID ANALGESICS .............................................................................................................................. 59
46. OSTEOPOROSIS AND HYPO/HYPERCALCEMIA ...................................................................................... 80
47. ANTICOAGULANTS ................................................................................................................................ 96
48. THYROID .............................................................................................................................................. 107
49. DIABETES ............................................................................................................................................. 114
50. ULCERATIVE COLITIS ........................................................................................................................... 136
51. IRRITABLE BOWEL SYNDROME ........................................................................................................... 140
52. ENURESIS/INCONTINENCE MANAGEMENT ........................................................................................ 145
53. DEMENTIA ........................................................................................................................................... 152
54. MULTIPLE SCLEROSIS .......................................................................................................................... 156
55. MUSCLE RELAXANTS ........................................................................................................................... 164
56. CYSTIC FIBROSIS .................................................................................................................................. 169
57. ANTI-GLAUCOMA ................................................................................................................................ 172
58. ANTI-INFECTIVE OPHTHALAMIC AGENTS ........................................................................................... 181
59. SMOKING CESSATION AGENTS ........................................................................................................... 184
60. EXPECTORANTS, ANTITUSSIVES, LAXATIVES, SCABICIDES & PEDICULICIDES ..................................... 186
61. ACID-BASE DISORDER .......................................................................................................................... 191
62. ORAL CONTRACEPTIVES AND IMPOTENCE AGENTS ........................................................................... 193
63. PSORIASIS ............................................................................................................................................ 201
64. VITAMINS AND THEIR SOURCES ......................................................................................................... 209
65. TERATOGENIC DRUGS ......................................................................................................................... 210
66. TOTAL PARENTERAL NUTRITION (TPN) ............................................................................................... 214
4
